BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 12482564)

  • 1. Role of IgG-seropositivity to Chlamydia pneumoniae in early thrombotic events after coronary stent placement.
    da Costa CP; Neumann FJ; Kastrati A; Stallforth I; Schmid M; Joghetai N; Prebeck S; Wagner H; Miethke T
    Atherosclerosis; 2003 Jan; 166(1):171-6. PubMed ID: 12482564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of Chlamydia pneumoniae infection with roxithromycin and effect on neointima proliferation after coronary stent placement (ISAR-3): a randomised, double-blind, placebo-controlled trial.
    Neumann F; Kastrati A; Miethke T; Pogatsa-Murray G; Mehilli J; Valina C; Jogethaei N; da Costa CP; Wagner H; Schömig A
    Lancet; 2001 Jun; 357(9274):2085-9. PubMed ID: 11445102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibody levels against Chlamydia pneumoniae and outcome of roxithromycin therapy in patients with acute myocardial infarction. Results from a sub-study of the randomised Antibiotic Therapy in Acute Myocardial Infarction (ANTIBIO) trial.
    Burkhardt U; Zahn R; Höffler U; Siegler KE; Frilling B; Weber M; Gottwik M; Wehr M; Seidel F; Rosocha S; Tebbe U; Senges J
    Z Kardiol; 2004 Sep; 93(9):671-8. PubMed ID: 15365734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Macrolide treatment after coronary stent placement.
    Arzt M; Pfeifer M; Holmer S; Riegger G
    Lancet; 2001 Dec 22-29; 358(9299):2168-9. PubMed ID: 11784661
    [No Abstract]   [Full Text] [Related]  

  • 5. Reduced progression of early carotid atherosclerosis after antibiotic treatment and Chlamydia pneumoniae seropositivity.
    Sander D; Winbeck K; Klingelhöfer J; Etgen T; Conrad B
    Circulation; 2002 Nov; 106(19):2428-33. PubMed ID: 12417538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Roxithromycin in prevention of acute coronary syndrome associated with Chlamydia pneumoniae infection: a randomized placebo controlled trial.
    Leowattana W; Bhuripanyo K; Singhaviranon L; Akaniroj S; Mahanonda N; Samranthin M; Pokum S
    J Med Assoc Thai; 2001 Dec; 84 Suppl 3():S669-75. PubMed ID: 12002908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trial of roxithromycin in subjects with asthma and serological evidence of infection with Chlamydia pneumoniae.
    Black PN; Blasi F; Jenkins CR; Scicchitano R; Mills GD; Rubinfeld AR; Ruffin RE; Mullins PR; Dangain J; Cooper BC; David DB; Allegra L
    Am J Respir Crit Care Med; 2001 Aug; 164(4):536-41. PubMed ID: 11520711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytomegalovirus, Chlamydia pneumoniae, and Helicobacter pylori IgG antibodies and restenosis after stent implantation: an angiographic and intravascular ultrasound study.
    Schiele F; Batur MK; Seronde MF; Meneveau N; Sewoke P; Bassignot A; Couetdic G; Caulfield F; Bassand JP
    Heart; 2001 Mar; 85(3):304-11. PubMed ID: 11179272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Previous cytomegalovirus infection and risk of coronary thrombotic events after stent placement.
    Neumann FJ; Kastrati A; Miethke T; Pogatsa-Murray G; Seyfarth M; Schömig A
    Circulation; 2000 Jan 4-11; 101(1):11-3. PubMed ID: 10618297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progression of early carotid atherosclerosis is only temporarily reduced after antibiotic treatment of Chlamydia pneumoniae seropositivity.
    Sander D; Winbeck K; Klingelhöfer J; Etgen T; Conrad B
    Circulation; 2004 Mar; 109(8):1010-5. PubMed ID: 14769704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Roxithromycin treatment prevents progression of peripheral arterial occlusive disease in Chlamydia pneumoniae seropositive men: a randomized, double-blind, placebo-controlled trial.
    Wiesli P; Czerwenka W; Meniconi A; Maly FE; Hoffmann U; Vetter W; Schulthess G
    Circulation; 2002 Jun; 105(22):2646-52. PubMed ID: 12045171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chlamydia pneumoniae, antibiotic treatment, and early atherosclerosis.
    Liuba P; Pesonen E; Paakkari I
    Circulation; 2003 Jun; 107(22):e205; author reply e205. PubMed ID: 12796417
    [No Abstract]   [Full Text] [Related]  

  • 13. Relationship between dyslipidemia, C-reactive protein and serological evidence of Chlamydia pneumoniae in Turkish patients with coronary artery diseases.
    Turkoglu C; Sonmez E; Aydinli A
    New Microbiol; 2004 Jul; 27(3):229-34. PubMed ID: 15460525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chlamydia pneumoniae IgG and IgA antibody titers and prognosis in patients with coronary heart disease: results from the CLARICOR trial.
    Hilden J; Lind I; Kolmos HJ; Als-Nielsen B; Damgaard M; Hansen JF; Hansen S; Helø OH; Hildebrandt P; Jensen GB; Kastrup J; Kjøller E; Nielsen H; Petersen L; Jespersen CM; Gluud C;
    Diagn Microbiol Infect Dis; 2010 Apr; 66(4):385-92. PubMed ID: 20226329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Percentage of asthmatic patients with acute bronchitis and Chlamydia pneumoniae seropositivity].
    Orfila J; Godard P
    Presse Med; 2000 Sep; 29(25):1439-41. PubMed ID: 11036523
    [No Abstract]   [Full Text] [Related]  

  • 16. [Chlamydia antibody titers in patients with coronary disease: relations to age and clinical stage].
    el-Rabadi K; Gottsauner-Wolf M; Christ G; Maurer G; Huber K
    Wien Klin Wochenschr; 2001 Oct; 113(19):727-30. PubMed ID: 11715750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of a brief course of azithromycin on soluble cell adhesion molecules and markers of inflammation in survivors of an acute coronary syndrome: A double-blind, randomized, placebo-controlled study.
    Hillis GS; Pearson CV; Harding SA; Sutherland S; Ludlam CA; Marioni JC; Prescott RJ; Fox KA; Flapan AD
    Am Heart J; 2004 Jul; 148(1):72-9. PubMed ID: 15215794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early carotid atherosclerosis and Chlamydia pneumoniae seropositivity: are there arguments to treat with antibiotics?
    Ieven MM; Hoymans VY; Bosmans JM
    Circulation; 2004 Aug; 110(7):e74-5; author reply e74-5. PubMed ID: 15313965
    [No Abstract]   [Full Text] [Related]  

  • 19. Progression of peripheral arterial occlusive disease is associated with Chlamydia pneumoniae seropositivity and can be inhibited by antibiotic treatment.
    Krayenbuehl PA; Wiesli P; Maly FE; Vetter W; Schulthess G
    Atherosclerosis; 2005 Mar; 179(1):103-10. PubMed ID: 15721015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chlamydia pneumoniae-atherosclerosis link: a sound concept in search for clinical relevance.
    Neumann FJ
    Circulation; 2002 Nov; 106(19):2414-6. PubMed ID: 12417534
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.